Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.15 USD | -0.25% |
|
-7.32% | +48.43% |
Valuation
Fiscal Period: Aprile | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Capitalization 1 | 62.16 | 28.14 | 33.15 | 39.78 | 45.99 | 102.6 |
Enterprise Value (EV) 1 | 62.43 | 37.69 | 44.1 | 74.14 | 79.61 | 118.5 |
P/E ratio | 41.1 x | -6 x | -9.02 x | -6.48 x | 65 x | 5.6 x |
Yield | 3.27% | 3.71% | - | - | - | - |
Capitalization / Revenue | 0.42 x | 0.19 x | 0.22 x | 0.24 x | 0.21 x | 0.5 x |
EV / Revenue | 0.43 x | 0.26 x | 0.3 x | 0.44 x | 0.36 x | 0.58 x |
EV / EBITDA | 12.8 x | 72.1 x | 181 x | 85.3 x | 9.75 x | 6.88 x |
EV / FCF | -79.2 x | 14.2 x | -34.2 x | -3.87 x | 18.9 x | 8.05 x |
FCF Yield | -1.26% | 7.03% | -2.92% | -25.9% | 5.29% | 12.4% |
Price to Book | 1.32 x | 0.73 x | 0.8 x | 1.11 x | 1.23 x | 1.85 x |
Nbr of stocks (in thousands) | 2,747 | 2,751 | 2,763 | 2,790 | 2,830 | 2,875 |
Reference price 2 | 22.63 | 10.23 | 12.00 | 14.26 | 16.25 | 35.70 |
Announcement Date | 7/11/19 | 7/27/20 | 7/15/21 | 7/1/22 | 6/30/23 | 6/28/24 |
Income Statement Evolution (Annual data)
Fiscal Period: April | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales 1 | 146.6 | 147.5 | 147.5 | 168.9 | 219.5 | 203.8 |
EBITDA 1 | 4.89 | 0.523 | 0.243 | 0.869 | 8.167 | 17.23 |
EBIT 1 | 2.319 | -2.131 | -2.444 | -1.9 | 5.3 | 14.1 |
Operating Margin | 1.58% | -1.44% | -1.66% | -1.13% | 2.41% | 6.92% |
Earnings before Tax (EBT) 1 | 2.134 | -2.866 | -2.617 | -2.485 | 4.498 | 13.12 |
Net income 1 | 1.529 | -4.687 | -3.672 | -6.126 | 0.738 | 18.75 |
Net margin | 1.04% | -3.18% | -2.49% | -3.63% | 0.34% | 9.2% |
EPS 2 | 0.5500 | -1.704 | -1.330 | -2.200 | 0.2500 | 6.380 |
Free Cash Flow 1 | -0.788 | 2.648 | -1.288 | -19.17 | 4.211 | 14.72 |
FCF margin | -0.54% | 1.79% | -0.87% | -11.35% | 1.92% | 7.23% |
FCF Conversion (EBITDA) | - | 506.31% | - | - | 51.56% | 85.46% |
FCF Conversion (Net income) | - | - | - | - | 570.56% | 78.52% |
Dividend per Share 2 | 0.7400 | 0.3800 | - | - | - | - |
Announcement Date | 7/11/19 | 7/27/20 | 7/15/21 | 7/1/22 | 6/30/23 | 6/28/24 |
Balance Sheet Analysis
Fiscal Period: Aprile | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net Debt 1 | 0.28 | 9.55 | 10.9 | 34.4 | 33.6 | 15.9 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 0.0571 x | 18.26 x | 45.03 x | 39.54 x | 4.116 x | 0.921 x |
Free Cash Flow 1 | -0.79 | 2.65 | -1.29 | -19.2 | 4.21 | 14.7 |
ROE (net income / shareholders' equity) | 3.52% | -10.7% | -9% | -15.5% | 3.64% | 40.2% |
ROA (Net income/ Total Assets) | 1.68% | -1.56% | -1.76% | -1.14% | 2.79% | 6.95% |
Assets 1 | 90.89 | 301.2 | 208.3 | 536.9 | 26.48 | 269.8 |
Book Value Per Share 2 | 17.10 | 14.00 | 14.90 | 12.80 | 13.20 | 19.30 |
Cash Flow per Share 2 | 3.880 | 1.590 | 1.880 | 1.590 | 2.850 | 8.200 |
Capex 1 | 4.21 | 2.47 | 2.4 | 1.91 | 4.15 | 4.37 |
Capex / Sales | 2.87% | 1.67% | 1.63% | 1.13% | 1.89% | 2.15% |
Announcement Date | 7/11/19 | 7/27/20 | 7/15/21 | 7/1/22 | 6/30/23 | 6/28/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+48.43% | 123M | |
+13.59% | 7.55B | |
+10.60% | 3.08B | |
-10.10% | 2.54B | |
+12.65% | 2.23B | |
-1.63% | 1.52B | |
+3.44% | 1.33B | |
+16.28% | 496M | |
-23.19% | 447M | |
-9.90% | 392M |
- Stock Market
- Equities
- KEQU Stock
- Financials Kewaunee Scientific Corporation